Genmab shared a post on X:
”By 2050, ovarian cancer diagnoses are projected to rise by more than 55%, impacting over half a million women globally (1).
On World Ovarian Cancer Day, we stand with the global community to drive awareness, earlier diagnosis, and improved care.
1 Global Cancer Observatory (GCO). International Agency for Research on Cancer, World Health Organization. Estimated numbers from 2022 to 2050, females aged 0–85+.”
Other Articles About Genmab On OncoDaily